Qualigen-Logo-Tag.png
Qualigen Therapeutics to Present at the H.C. Wainwright Global Investment Conference
May 20, 2022 09:15 ET | Qualigen Therapeutics, Inc.
CARLSBAD, Calif., May 20, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers...
Qualigen-Logo-Tag.png
Qualigen Therapeutics Resumes Worldwide Distribution and Commercial Control Over FastPack®
April 05, 2022 09:15 ET | Qualigen Therapeutics, Inc.
Company Prepared for Growth and Improved Profitability of its Diagnostics Business CARLSBAD, Calif., April 05, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified...
Logo.png
BioRestorative Therapies Announces Notice of Allowance for New Patent Application in Japan and Expansion of ThermoStem® IP Portfolio
February 02, 2022 08:00 ET | BioRestorative Therapies, Inc
Notice of Allowance Grants Protection for Generating Implantable Three-Dimensional Scaffolds MELVILLE, N.Y., Feb. 02, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or...
New.jpg
BioRestorative Therapies Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq
October 26, 2021 16:05 ET | BioRestorative Therapies, Inc
MELVILLE, NY, Oct. 26, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BRTX” or the “Company”) (OTC: BRTX), a life sciences company focused on adult stem cell-based therapies, today...
BRT-logo-final.png
BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program
September 23, 2021 09:00 ET | BioRestorative Therapies, Inc
MELVILLE, N.Y., Sept. 23, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BRT-logo-final.png
BioRestorative Therapies Awarded One of Top 10 Spine Device Companies by MedTech Outlook
August 19, 2021 06:00 ET | BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 19, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,...
BRT-logo-final.png
BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering
August 09, 2021 11:58 ET | BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
BRT-logo-final.png
BioRestorative Therapies to Present at the Emerging Growth Conference on June 9, 2021
June 07, 2021 06:00 ET | BioRestorative Therapies, Inc
BioRestorative Therapies invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the online Emerging Growth Conference. ...
BioStem Technologies Main Logo.jpg
BioStem Technologies, Announces Filing of 2020 Quarterly Reports
December 24, 2020 14:00 ET | BioStem Technologies, Inc.
Pompano Beach, Fl, Dec. 24, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...
Medium Juva Logo (002).png
CORRECTION—Juva Life Commences Trading Under CSE Ticker Symbol JUVA
November 17, 2020 11:55 ET | Juva Life Inc.
VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Previous release had an incorrect area code on the contact phone number (888 should have been 833). This has been corrected. Juva...